EU Health Tech Assessments: Majority Favor Continuing Beyond 2020
By Zachary Brennan -
Published 15 May 2017
A majority of respondents to a European Commission questionnaire says health technology assessment (HTA) cooperation at the EU level should continue beyond 2020.
Categories: News, Europe, EC, EMA, MHRA, NICE, Biologics and biotechnology, Drugs, In vitro diagnostics, Medical Devices, Regulatory intelligence, Regulatory strategy
Tags: HTA, health technology assessments, European Commission report